Apoptotic enteropathy caused by antimetabolites and TNF-α antagonists

Journal of Clinical Pathology

Volumn 67, Issue 7, 2014, Pages 582-586

  Soldini, Davide ^a   Gaspert, Ariana ^a   Montani, Matteo ^a,b   Reineke, Tanja ^a   Rogler, Gerhard ^a   Odze, Robert ^c   Weber, Achim ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; CAPECITABINE; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; APOPTOSIS; APOPTOTIC ENTEROPATHY; ARTICLE; CASE REPORT; DIARRHEA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENDOSCOPY; ENTEROPATHY; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTESTINE BIOPSY; INTESTINE CRYPT; INTESTINE ULCER; LAMINA PROPRIA; NAUSEA; NEUTROPHIL; PRIORITY JOURNAL;

APOPTOSIS; DIAGNOSTICS; GASTROENTEROLOGY;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BIOPSY; COLON; COLONIC DISEASES; COLONIC POUCHES; DEOXYCYTIDINE; DIARRHEA; ENDOSCOPY, GASTROINTESTINAL; FLUOROURACIL; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; METHOTREXATE; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904347986     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202199     Document Type: Article

References (26)

1. Allison AC, Eugui EM. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 2005;80:S181-90. (Pubitemid 41552905)
2. Papadimitriou JC, Cangro CB, Lustberg A, et al. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern. Int J Surg Pathol 2003;11:295-302. (Pubitemid 37433288)
3. Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol 2008;32:1367-72.
4. Oble DA, Mino-Kenudson M, Goldsmith J, et al. Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysis. Am J Surg Pathol 2008;32:1130-7.
5. Schmiegelow K. Advances in individual prediction of methotrexate toxicity: a review. Br J Haematol 2009;146:489-503.
6. Sun W. Evolution of capecitabine dosing in colorectal cancer. Clin Colorectal Cancer 2010;9:31-9.
7. Kerensky TA, Gottlieb AB, Yaniv S, et al. Etanercept: efficacy and safety for approved indications. Expert Opin Drug Saf 2012;11:121-39.
8. Papa A, Mocci G, Bonizzi M, et al. Use of infliximab in particular clinical settings: management based on current evidence. Am J Gastroenterol 2009;104:1575-86.
9. Lee S, de Boer WB, Subramaniam K, et al. Pointers and pitfalls of mycophenolate-associated colitis. J Clin Pathol 2013;66:8-11.
10. De Petris G, Gatius Caldero S, Chen L, et al. Histopathological Changes in the Gastrointestinal Tract Due to Medications: An Update for the Surgical Pathologist (Part II of II). Int J Surg Pathol 2014;22:120-8.
11. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012;87:732-8.
12. Attar SM. Adverse effects of low dose methotrexate in rheumatoid arthritis patients. A hospital-based study. Saudi Med J 2010;30:909-15.
13. Dalle IJ, Maes BD, Geboes KP, et al. Crohn's-like changes in the colon due to mycophenolate? Colorectal Dis 2005;7:27-34. (Pubitemid 40246419)
14. Zeeh J, Inglin R, Baumann G, et al. Mycophenolate mofetil impairs healing of left-sided colon anastomoses. Transplantation 2001;71:1429-35. (Pubitemid 32507117)
15. Lee EY, Clouse RE, Aliperti G, et al. Small intestinal lesion resembling graft-vs-host disease. A case report in immunodeficiency and review of the literature. Arch Pathol Lab Med 1991;115:529-32.
16. Snover DC, Weisdorf SA, Vercellotti GM, et al. A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol 1985;16:387-92. (Pubitemid 15071535)
17. Schiemann U, Kellner H. [Gastrointestinal side effects in the therapy of rheumatologic diseases]. Z Gastroenterol 2002;40:937-43.
18. Dallocchio A, Canioni D, Ruemmele F, et al. Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study. Rheumatology (Oxford) 2010;49:1694-8.
19. Smith AM, Rahman FZ, Hayee B, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009;206:1883-97.
20. Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006;12:31-47. (Pubitemid 43034096)
21. Lee FD. Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J Clin Pathol 1993;46:118-22. (Pubitemid 23076340)
22. Selbst MK, Ahrens WA, Robert ME, et al. Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil. Mod Pathol 2009;22:737-43.
23. Jana NR. NSAIDs and apoptosis. Cell Mol Life Sci 2008;65:1295-301.
24. Thiefin G, Beaugerie L. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine 2005;72:286-94. (Pubitemid 40994974)
25. Klein M, Linnemann D, Rosenberg J. Non-steroidal anti-inflammatory drug-induced colopathy. BMJ Case Rep Published Online first: 8 Feb 2011. doi:10.1136/bcr.10.2010.3436
26. Chlumska A, Krekulova L, Mukeninabl P, et al. Mucosal changes after a polyethylene glycol bowel preparation for colonoscopy are less than those after sodium phosphate. Cesk Patol 2011;47:130-1.